AI model for classifying brain and spinal tumors
Part of Brain & nervous system, Cancer clinical trials.
This study uses artificial intelligence (AI) to analyze images of brain and spinal tumor tissue samples. The goal is to develop a tool that can accurately classify tumor types, which may help doctors make faster and more precise diagnoses in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery to remove a brain or spinal tumor at Huashan Hospital or Shandong Provincial Hospital.
- The tumor was diagnosed by a pathologist as a primary or secondary central nervous system tumor.
- Your tissue slides or digital images from the hospital are available and of good quality for computer analysis.
- Your de-identified medical information, like age, sex, and tumor details, is available for the study.
- You do not have any severe problems with the slides, such as folds, bubbles, or poor staining, that would affect the analysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to analyze MRI scans from people diagnosed with a type of brain tumor called glioma. It aims to better understand the cancer from diagnosis through treatment, which could help guide future care.
This study is testing if artificial intelligence (AI) can look at microscope slides of your brain tumor tissue to guess its genetic makeup. It uses data already collected from your routine care, so there is no extra treatment or medicine involved.
This study is building an artificial intelligence system to improve how doctors diagnose brain conditions using scans like MRI. If you are diagnosed with one of the listed conditions, your scans and medical information may help train the AI.
This trial uses artificial intelligence to analyze MRI scans and help doctors identify the type of brain tumor in children. It aims to improve treatment planning by providing a non-invasive way to predict the tumor subtype before surgery.
This trial uses artificial intelligence to analyze CT and MRI scans of solid tumors. The goal is to better understand how tumors respond to non-surgical treatments, which could help doctors make more personalized treatment decisions.
This trial uses an AI computer program to predict the molecular features of a primary brain tumor (glioma) by looking at tumor tissue images. Your results could help researchers better match glioma subtypes to more tailored care, using information obtained from the surgery sample.
Hear when a new Brain Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.